These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1252 related articles for article (PubMed ID: 34963339)

  • 21. Recent advances in the CRISPR genome editing tool set.
    Moon SB; Kim DY; Ko JH; Kim YS
    Exp Mol Med; 2019 Nov; 51(11):1-11. PubMed ID: 31685795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering guide RNA to reduce the off-target effects of CRISPR.
    Wu J; Yin H
    J Genet Genomics; 2019 Nov; 46(11):523-529. PubMed ID: 31902584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome editing for plant research and crop improvement.
    Zhan X; Lu Y; Zhu JK; Botella JR
    J Integr Plant Biol; 2021 Jan; 63(1):3-33. PubMed ID: 33369120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application and optimization of CRISPR/Cas system in bacteria].
    Fu J; Yang F; Xie H; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR Diagnosis and Therapeutics with Single Base Pair Precision.
    Lee SH; Park YH; Jin YB; Kim SU; Hur JK
    Trends Mol Med; 2020 Mar; 26(3):337-350. PubMed ID: 31791730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
    Tan JJ; Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
    Yang F; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for the CRISPR-Based Therapeutics.
    Li B; Niu Y; Ji W; Dong Y
    Trends Pharmacol Sci; 2020 Jan; 41(1):55-65. PubMed ID: 31862124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concerns regarding 'off-target' activity of genome editing endonucleases.
    Kadam US; Shelake RM; Chavhan RL; Suprasanna P
    Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted Base Editing Systems Are Available for Plants.
    Marzec M; Hensel G
    Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.